Effectiveness of Short-Term Olanzapine in Patients With Bipolar I Disorder, With or Without Comorbidity With Substance Use Disorder
The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Prognosis of comorbid bipolar disorder (BD) and drug abuse is poor. We assessed the efficacy of olanzapine in manic or mixed BD patients, with (SUD) or without (N-SUD) comorbidity with substance use disorder (SUD) and its effect on drug abuse, days of abuse, and craving. METHODS: Eighty patients with BD-I (40 SUD) were hospitalized for a manic or mixed episode and received add-on olanzapine. Assessments were conducted at admission, discharge, and 4 and 8 weeks after discharge. Primary outcome was the proportion of responders and remitters in each group. We used a logistic regression model to adjust for possible confounders. We assessed craving and drug-abuse days with a visual analog scale and the Timeline Follow-Back. RESULTS: SUD and N-SUD were similar on response and remission, adjusted for sex, age, years ill, age at first episode, first episode depressive, number of hospitalizations, and duration of hospitalization (odds ratio, 1.09; 95% confidence interval, 1.02-2.29). Mood rating scores dropped significantly from baseline to end point in both groups. Timeline follow-back decreased in SUD from 22.5 to 7.3 at 8 weeks postdischarge, whereas craving dropped from 8.3 to 5.1 (P < 0.03). CONCLUSIONS: The effectiveness of short-term olanzapine in BD-I mania or mixed mania did not differ according to SUD comorbidity. Treatment was followed by less substance use/abuse and craving in comorbid bipolar-SUD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Olanzapine add‐on therapy was effective in decreasing manic symptoms and measures of substance use such as reduction in cravings in hospitalized inpatients (level 2).718”
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
GELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
Sensitivity and accuracy of the visual analogue scale: a psycho‐ physical classroom experiment.
Maxwell, C. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb01676.x · Cited by 465
Kuroki, T., Meltzer, H. Y., & Ichikawa, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38019-x · Cited by 351
Salloum, I. M., Cornelius, J. R., Daley, D. C., Kirisci, L., Himmelhoch, J. M., & Thase, M. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.37 · Cited by 271
Psychological measurements in psychopharmacology
Pichot, P., & Olivier-Martin, R. (1974) · KARGER eBooks · Cited by 266
Li, X.-M., Perry, K. W., Wong, D. T., & Bymaster, F. P. (1998) · Psychopharmacology · doi:10.1007/s002130050551 · Cited by 189
The Brief Psychiatric Rating Scale in Psychopharmacology Research
Overall, J. E. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395069 · Cited by 188
Zhang, W., & Bymaster, F. P. (1999) · Psychopharmacology · doi:10.1007/s002130050834 · Cited by 159
The relationship between substance abuse and bipolar disorder.
Brady, K. T., & Sonne, S. C. (1995) · PubMed · Cited by 154
The Effect of Olanzapine on Craving and Alcohol Consumption
Hutchison, K. E., Ray, L. A., Sandman, E., Goodworth, M.-C. R., Peters, A., Davidson, D., & Swift, R. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300917 · Cited by 128
Quetiapine in bipolar disorder and cocaine dependence
Brown, E. S., Nejtek, V. A., Perantie, D. C., & Bobadilla, L. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.02229.x · Cited by 122
Olanzapine Reduces Craving for Alcohol: A DRD4 VNTR Polymorphism by Pharmacotherapy Interaction
Hutchison, K. E., Wooden, A., Swift, R. M., Smolen, A., McGeary, J. E., Adler, L. E., & Paris, L. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300264 · Cited by 122
Brown, E. S., Jeffress, J., Liggin, J. D. M., Garza, M., & Beard, L. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0613 · Cited by 118
(1995) · PubMed · Cited by 115
Olanzapine treatment for patients with schizophrenia and substance abuse
Littrell, K. H., Petty, R. G., Hilligoss, N. M., Peabody, C. D., & Johnson, C. G. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00205-7 · Cited by 110
Anton, R. F., Kranzler, H., Breder, C., Marcus, R. N., Carson, W. H., & Han, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181602fd4 · Cited by 106
A pilot trial of olanzapine for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Sparkman, T., & O’Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00009-7 · Cited by 91
Lamotrigine in Patients With Bipolar Disorder and Cocaine Dependence
Brown, E. S., Nejtek, V. A., Perantie, D. C., Orsulak, P. J., & Bobadilla, L. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0213 · Cited by 90
Smelson, D. A., Ziedonis, D., Williams, J., Losonczy, M. F., Williams, J., Steinberg, M. L., & Kaune, M. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000194624.07611.5e · Cited by 76
Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse
Conley, R. R., Kelly, D. L., & Gale, E. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00062-0 · Cited by 73
Cocaine Abuse in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol
Sayers, S. L., Campbell, E. C., Kondrich, J., Mann, S. C., Cornish, J., O'Brien, C., & Caroff, S. N. (2005) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000165089.14736.bf · Cited by 68
Lithium treatment for cocaine abusers with bipolar spectrum disorders
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.5.655 · Cited by 65
Effects of lamotrigine in patients with bipolar disorder and alcohol dependence
Rubio, G., López‐Muñoz, F., & Alamo, C. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00292.x · Cited by 64
Comparison of Olanzapine to Risperidone in Substance‐Abusing Individuals with Schizophrenia
Akerele, E., & Levin, F. R. (2007) · The American Journal on Addictions · doi:10.1080/10550490701389658 · Cited by 63
Lamotrigine for bipolar disorder and comorbid cocaine dependence: A replication and extension study
Brown, E. S., Perantie, D. C., Dhanani, N., Beard, L., Orsulak, P. J., & Rush, A. J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.001 · Cited by 57
Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder.
Brady, K. T., Sonne, S. C., Malcolm, R. J., Randall, C. L., Simpson, K., Dansky, B. S., Roberts, J. S., & Brondino, M. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.3.276 · Cited by 55
Olanzapine attenuates cue-elicited craving for tobacco
Hutchison, K. E., Goodworth, M.-C. R., NIAURA, R. S., Swift, R. M., Pickworth, W. B., & Sobik, L. E. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1837-3 · Cited by 50
van Nimwegen, L. J., de Haan, L., van Beveren, N. J., van der Helm, M., van den Brink, W., & Linszen, D. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300610 · Cited by 50
Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence
Vergne, D. E., & Anton, R. F. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966731 · Cited by 39
Self-citationOlanzapine Treatment for Patients With Schizophrenia and Cocaine Abuse
Tsuang, J., Marder, S. R., Han, A., & Hsieh, W. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1214c · Cited by 37
Quetiapine for Alcohol Use and Craving in Bipolar Disorder
Longoria, J., Brown, E. S., Perantie, D. C., Bobadilla, L., & Nejtek, V. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000106230.36344.b1 · Cited by 37
Olanzapine in Cocaine Dependence: A Double‐Blind, Placebo‐Controlled Trial
Hamilton, J. D., Nguyen, Q. X., Gerber, R. M., & Rubio, N. B. (2009) · The American Journal on Addictions · doi:10.1080/10550490802544318 · Cited by 33
Gerra, G., Di Petta, G., D'Amore, A., Iannotta, P., Bardicchia, F., Falorni, F., Coacci, A., Strepparola, G., Campione, G., Lucchini, A., et al. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31803354f6 · Cited by 32
Ketanserin Treatment of Tourette’s Syndrome in Children
Bonnier, C., Nassogne, M., & Evrard, P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1122a · Cited by 25
Differential effects of olanzapine at dopamine D 1 and D 2 receptors in dopamine depleted animals
Ninan, I., & Kulkarni, S. (1999) · Psychopharmacology · doi:10.1007/s002130050877 · Cited by 19
Potential Use of Olanzapine in Treatment of Substance Dependence Disorders
Sattar, S. P., Grant, K. M., Bhatia, S. C., & Petty, F. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085417.08426.54 · Cited by 18
Olanzapine for Cocaine Cravings and Relapse Prevention
Sattar, S. P., & Bhatia, S. C. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0819a · Cited by 12
Valproate for Alcoholics With Bipolar Disorder
Sonne, S. C., & Brady, K. T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1122 · Cited by 9
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Associations Between Pubertal Stage and Depression: A Systematic Review of the Literature
Stumper, A., & Alloy, L. B. (2021) · Child Psychiatry & Human Development · doi:10.1007/s10578-021-01244-0 · Cited by 53
Allostasis as a Conceptual Framework Linking Bipolar Disorder and Addiction
Pettorruso, M., De Risio, L., Di Nicola, M., Martinotti, G., Conte, G., & Janiri, L. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00173 · Cited by 38
Pharmacotherapies for co‐occurring substance use and bipolar disorders: A systematic review
Coles, A. S., Sasiadek, J., & George, T. P. (2019) · Bipolar Disorders · doi:10.1111/bdi.12794 · Cited by 39
Lorenzo, R. D., Galliani, A., Ferri, P., Landi, G., & Guicciardi, A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65896 · Cited by 38
Metadata
- Authors
- Sani, G., Kotzalidis, G. D., Vöhringer, P., Pucci, D., Simonetti, A., Manfredi, G., Savoja, V., Tamorri, S. M., Mazzarini, L., Pacchiarotti, I., Telesforo, C. L., Ferracuti, S., Brugnoli, R., Ambrosi, E., Caloro, M., Del Casale, A., Koukopoulos, A. E., Vergne, D. E., Girardi, P., & Ghaemi, S. N.
- Affiliations
- Azienda Ospedaliera Sant'Andrea (IT)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Tufts University (US)
- Sapienza University of Rome (IT)
- Fondazione Santa Lucia (IT)
- Azienda Sanitaria Locale Viterbo (IT)
- Corresponding author
- Sani, Gabriele
- Kotzalidis, Georgios D.
- Pucci, Daniela
- Simonetti, Alessio
- Manfredi, Giovanni
- Savoja, Valeria
- Tamorri, Stefano Maria
- Mazzarini, Lorenzo
- Pacchiarotti, Isabella
- Telesforo, Carla Ludovica
- Ferracuti, Stefano
- Brugnoli, Roberto
- Ambrosi, Elisa
- Caloro, Matteo
- Koukopoulos, Alexia E.
- Girardi, Paolo
- ORCID
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2013-04
- Volume
- 33
- Issue
- 2
- Pages
- 231-235
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2327033044
- Cited by
- 27
- References
- 46
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 2 · 2015: 3 · 2014: 2
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- olanzapine, bipolar I disorder, substance use comorbidity, manic episodes, mixed states, craving, mood stabilizers, treatment response and remission
- MeSH terms
- Olanzapine, Adult, Benzodiazepines, Bipolar Disorder, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Time Factors, Antipsychotic Agents, Logistic Models, Case-Control Studies, Treatment Outcome, Diagnosis, Dual (Psychiatry), Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.